New NephSAP Issue - "Secondary Glomerular Diseases"

By ASN Staff

NephSAP Volume 17, Number 4, September 2018

Please read the full issue.

Secondary Glomerular Diseases

The kidney, more specifically the glomerulus, is often injured during systemic diseases. These secondary glomerulonephritides often manifest with proteinruia, heamturia, and impaired kidney function occasionally. Diagnosis is challenging, and treatments frequently incorporate immunomodulatory drugs with potential for severe side-effects. The 2018 Secondary Glomerular Diseases issue of NephSAP presents the reader with the latest updates on diagnosis, treatment, and outcomes of a wide range of glomerular diseases likely encountered in practice. Recommendations are offered based on the best available evidence. All relevant, randomized, controlled clinical trials are discussed. The reader will also be introduced to reasearch-based findings of special clinical relevance such as biomarkers of disease activity and response. Gaps in knowledge are indicated, and considered in the context of future investigation. After studying this issue of NephSAP, readers are invited to test their knowledge in a series of challanging case studies and questions, accompanied by detailed explanations of the best answers.

Learning Objectives

  1. Understand and interpret clinical, laboratory, and histologic manifestations of secondary glomerular diseases to improve diagnostic and prognostic skills.
  2. Understand pathogenic mechanisms of secondary glomerular diseases and their applications to patient management.
  3. Describe the rationale, efficacy, and safety of current and emerging therapeutic approaches to glomerular diseases.
Category:
Subcategory:
Author:
ASN Staff
Article Image:
Body:

NephSAP Volume 17, Number 4, September 2018

Please read the full issue.

Secondary Glomerular Diseases

The kidney, more specifically the glomerulus, is often injured during systemic diseases. These secondary glomerulonephritides often manifest with proteinruia, heamturia, and impaired kidney function occasionally. Diagnosis is challenging, and treatments frequently incorporate immunomodulatory drugs with potential for severe side-effects. The 2018 Secondary Glomerular Diseases issue of NephSAP presents the reader with the latest updates on diagnosis, treatment, and outcomes of a wide range of glomerular diseases likely encountered in practice. Recommendations are offered based on the best available evidence. All relevant, randomized, controlled clinical trials are discussed. The reader will also be introduced to reasearch-based findings of special clinical relevance such as biomarkers of disease activity and response. Gaps in knowledge are indicated, and considered in the context of future investigation. After studying this issue of NephSAP, readers are invited to test their knowledge in a series of challanging case studies and questions, accompanied by detailed explanations of the best answers.

Learning Objectives

  1. Understand and interpret clinical, laboratory, and histologic manifestations of secondary glomerular diseases to improve diagnostic and prognostic skills.
  2. Understand pathogenic mechanisms of secondary glomerular diseases and their applications to patient management.
  3. Describe the rationale, efficacy, and safety of current and emerging therapeutic approaches to glomerular diseases.
Date:
Wednesday, September 12, 2018